The splicing factor SRSF3, which is the smallest member of the serine/arginine rich protein family, is a proto-oncogene OE in many cancers, including breast cancer, and is known to regulate cancer progression, metastasis, prognosis, and drug resistance [31, 32]. Here, SRSF3 is linked to breast carcinoma.